The company now projects annual adjusted earnings per share between $3.10 and $3.14, a significant upward revision from its prior forecast of $2.95 to $3.05. This momentum is supported by an 8% increase in quarterly revenue, which reached $1.11 billion—exceeding the $1.07 billion target set by market observers.

Growth was particularly pronounced in the intelligent operating solutions segment, which saw a 9.8% revenue lift, while the advanced healthcare solutions division contributed a 3.7% increase. Investors responded positively to the results, driving shares up 3.9% to $64 during premarket trading.